A randomized phase III trial in patients with advanced adenocarcinoma of the stomach receiving first-line chemotherapy with fluorouracil, leucovorin and oxaliplatin (FLO) versus fluorouracil, leucovorin and cisplatin (FLP)

被引：0
|
作者：
Al-Batran, S.
Hartmann, J. T.
Probst, S.
Hofheinz, R.
Stoehlmacher, J.
Schmalenberg, H.
Hollerbach, S.
Schuch, G.
Homann, N.
Jaeger, E.
机构：
[1] Krankenhaus NW Frankfurt, Frankfurt, Germany
[2] Univ Tubingen, Tubingen, Germany
[3] Stadt Kliniken, Bielefeld, Germany
[4] Univ Klinikum Mannheim, Mannheim, Germany
[5] Univ Hosp Carl Gustav Carus, Dresden, Germany
[6] Univ Klinikum Jena, Jena, Germany
[7] Allgemeines Krankenhaus, Celle, Germany
[8] Univ Hamburg, Hosp Eppendorf, D-20246 Hamburg, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：934S / 934S
页数：1
相关论文
共 50 条
  • [31] Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer:: The Gruppo Oncologico Nord Ovest
    Falcone, Alfredo
    Ricci, Sergio
    Brunetti, Isa
    Pfanner, Elisabetta
    Allegrini, Giacomo
    Barbara, Cecilia
    Crino, Lucio
    Benedetti, Giovanni
    Evangelista, Walter
    Fanchini, Laura
    Cortesi, Enrico
    Picone, Vincenzo
    Vitello, Stefano
    Chiara, Silvana
    Granetto, Cristina
    Porcile, Gianfranco
    Fioretto, Luisa
    Orlandini, Cinzia
    Andreuccetti, Michele
    Masi, Gianluca
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (13) : 1670 - 1676
  • [32] Cisplatin, Fluorouracil in Bolus Injection, and Leucovorin in First-Line Therapy for Advanced Gastric Cancer as an Alternative to Protocols With Infusional Fluorouracil
    Coelho, Rafael C.
    Abreu, Pedro D. P.
    Monteiro, Mariana R.
    Stramosk, Ana Paula
    Garces, Alvaro Henrique, I
    Melo, Andreia Cristina
    Graudenz, Marcia S.
    Andrade, Carlos Jose C.
    JOURNAL OF GLOBAL ONCOLOGY, 2019, 5 : 1 - 8
  • [33] A Prospective Study to Evaluate the Efficacy of the Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Chemotherapy Regimen in Patients with Locally Advanced and Metastatic Adenocarcinoma of Stomach
    Srinivasalu, Vijay Kumar
    Philip, Arun
    Pillai, Ranjini
    Jose, Wesley M.
    Keechilat, Pavithran
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2022, 43 (02) : 153 - 158
  • [34] Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin:: A study of the arbeitsgemeinschaft internistische onkologie
    Al-Batran, Salah-Eddin
    Hartmann, Joerg Thomas
    Probst, Stephan
    Schmalenberg, Harald
    Hollerbach, Stephan
    Hofheinz, Ralf
    Rethwisch, Volker
    Seipelt, Gernot
    Homann, Nils
    Wilhelm, Gerhard
    Schuch, Gunter
    Stoehlmacher, Jan
    Derigs, Hans Guenter
    Hegewisch-Becker, Susanna
    Grossmann, Johannes
    Pauligk, Claudia
    Atmaca, Akin
    Bokemeyer, Carsten
    Knuth, Alexander
    Jaeger, Elke
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (09) : 1435 - 1442
  • [35] PaFLO: Pazopanib with 5-fluorouracil, leucovorin, and oxaliplatin (FLO) as first-line treatment in advanced gastric cancer: A randomized phase II study of the Arbeitsgemeinschaft internistische Onkologie (AIO).
    Breithaupt, Kirstin
    Bichev, Dmitry
    Lorenz, Mario
    Bohnen, Daniela
    Dogan, Yasemin
    Schlattmann, Peter
    Al-Batran, Salah-Eddin
    Moehler, Markus Hermann
    Thuss-Patience, Peter C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [36] Randomized trial of 5-fluorouracil, leucovorin and cisplatin in advanced pancreatic cancer
    Huguier, M
    Barrier, A
    Valinas, R
    Flahault, A
    Adloff, M
    Pezet, D
    Jaeck, D
    Millat, B
    HEPATO-GASTROENTEROLOGY, 2001, 48 (39) : 875 - 878
  • [37] Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study
    B Neri
    P Pantaleo
    E Giommoni
    R Grifoni
    C Paoletti
    V Rotella
    D Pantalone
    A Taddei
    A Mercatelli
    P Tonelli
    British Journal of Cancer, 2007, 96 : 1043 - 1046
  • [38] Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study
    Neri, B.
    Pantaleo, P.
    Giommoni, E.
    Grifoni, R.
    Paoletti, C.
    Rotella, V.
    Pantalone, D.
    Taddei, A.
    Mercatelli, A.
    Tonelli, P.
    BRITISH JOURNAL OF CANCER, 2007, 96 (07) : 1043 - 1046
  • [39] 5-Fluorouracil/Leucovorin, Oxaliplatin and Irinotecan (FOLFOXIRI) as First-Line Treatment of Advanced Gastric Cancer
    Grande, C.
    Martinez, M.
    Villanueva, M. J.
    Huidobro, G.
    Casal, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S469 - S469
  • [40] Phase III study of 5-fluorouracil/leucovorin plus oxaliplatin versus capecitabine plus oxaliplatin as first line therapy in patients with advanced colorectal cancer (ACRC)
    Porschen, R
    Arkenau, T
    Kubicka, S
    Schmoll, HJ
    Seufferlein, T
    Graeven, U
    Grothey, A
    GASTROENTEROLOGY, 2005, 128 (04) : A438 - A438
12345